BCM
Bridgeway Capital Management’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-603,600
| Closed | -$37.8M | – | 1362 |
|
2018
Q4 | $37.8M | Sell |
603,600
-183,200
| -23% | -$11.5M | 0.5% | 75 |
|
2018
Q3 | $60.7M | Sell |
786,800
-297,750
| -27% | -$23M | 0.59% | 51 |
|
2018
Q2 | $76.8M | Buy |
1,084,550
+20,175
| +2% | +$1.43M | 0.78% | 18 |
|
2018
Q1 | $80.2M | Sell |
1,064,375
-20,600
| -2% | -$1.55M | 0.86% | 13 |
|
2017
Q4 | $77.7M | Buy |
1,084,975
+334,710
| +45% | +$24M | 0.84% | 15 |
|
2017
Q3 | $60.8M | Buy |
750,265
+434,310
| +137% | +$35.2M | 0.69% | 35 |
|
2017
Q2 | $22.4M | Sell |
315,955
-10,825
| -3% | -$766K | 0.27% | 104 |
|
2017
Q1 | $22.2M | Buy |
326,780
+6,870
| +2% | +$467K | 0.27% | 104 |
|
2016
Q4 | $22.9M | Buy |
319,910
+42,790
| +15% | +$3.06M | 0.3% | 99 |
|
2016
Q3 | $21.9M | Buy |
277,120
+9,950
| +4% | +$787K | 0.33% | 95 |
|
2016
Q2 | $22.3M | Sell |
267,170
-14,010
| -5% | -$1.17M | 0.35% | 99 |
|
2016
Q1 | $25.8M | Buy |
281,180
+935
| +0.3% | +$85.9K | 0.43% | 75 |
|
2015
Q4 | $28.4M | Buy |
280,245
+740
| +0.3% | +$74.9K | 0.53% | 36 |
|
2015
Q3 | $27.4M | Buy |
279,505
+6,040
| +2% | +$593K | 0.57% | 21 |
|
2015
Q2 | $32M | Sell |
273,465
-14,260
| -5% | -$1.67M | 0.63% | 17 |
|
2015
Q1 | $28.2M | Buy |
287,725
+25,400
| +10% | +$2.49M | 0.58% | 19 |
|
2014
Q4 | $24.7M | Buy |
262,325
+29,980
| +13% | +$2.83M | 0.56% | 25 |
|
2014
Q3 | $24.7M | Sell |
232,345
-10,110
| -4% | -$1.08M | 0.62% | 18 |
|
2014
Q2 | $20.1M | Sell |
242,455
-2,675
| -1% | -$222K | 0.53% | 30 |
|
2014
Q1 | $17.4M | Buy |
245,130
+15,930
| +7% | +$1.13M | 0.5% | 36 |
|
2013
Q4 | $17.2M | Buy |
229,200
+177,500
| +343% | +$13.3M | 0.52% | 36 |
|
2013
Q3 | $3.25M | Sell |
51,700
-400
| -0.8% | -$25.1K | 0.11% | 189 |
|
2013
Q2 | $2.67M | Buy |
+52,100
| New | +$2.67M | 0.11% | 232 |
|